• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-甲基化5-羟基-2-(二丙基氨基)四氢萘:中枢多巴胺受体刺激活性

C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.

作者信息

Hacksell U, Johansson A M, Arvidsson L, Nilsson J L, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P

出版信息

J Med Chem. 1984 Aug;27(8):1003-7. doi: 10.1021/jm00374a012.

DOI:10.1021/jm00374a012
PMID:6431102
Abstract

C1-Methylated derivatives of the potent dopaminergic agonist 5-hydroxy-2-(di-n-propylamino)tetralin (6) have been synthesized and tested for central dopamine (DA) receptor stimulating activity, by using biochemical and behavioral tests in rats. Both cis- and trans-5-hydroxy-1-methyl-2-(di-n-propylamino) tetralin (4 and 3) may be classified as central DA-receptor agonists, albeit of lower potency than 6. The results obtained indicate that both 4 and 3 display DA-autoreceptor stimulation capacity. However, only one of the isomers, trans-3, is able to elicit clear-cut postsynaptic DA receptor agonist actions at larger doses. 5-Hydroxy-1,1-dimethyl-2-(n-propylamino) tetralin (5) was found to be inactive.

摘要

强效多巴胺能激动剂5-羟基-2-(二正丙基氨基)四氢萘(6)的C1-甲基化衍生物已被合成,并通过对大鼠进行生化和行为测试来检测其对中枢多巴胺(DA)受体的刺激活性。顺式和反式5-羟基-1-甲基-2-(二正丙基氨基)四氢萘(4和3)均可归类为中枢DA受体激动剂,尽管其效力低于6。所得结果表明,4和3均具有DA自身受体刺激能力。然而,只有反式异构体3在较大剂量时能够引发明显的突触后DA受体激动作用。5-羟基-1,1-二甲基-2-(正丙基氨基)四氢萘(5)被发现无活性。

相似文献

1
C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.1-甲基化5-羟基-2-(二丙基氨基)四氢萘:中枢多巴胺受体刺激活性
J Med Chem. 1984 Aug;27(8):1003-7. doi: 10.1021/jm00374a012.
2
C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation.C3-甲基化的5-羟基-2-(二丙基氨基)四氢萘:对中枢多巴胺受体激活具有重要意义的构象和空间参数。
J Med Chem. 1987 Jul;30(7):1135-44. doi: 10.1021/jm00390a004.
3
(+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.(+)-顺式-8-羟基-1-甲基-2-(二正丙基氨基)四氢萘:一种强效且高度立体选择性的5-羟色胺受体激动剂。
J Med Chem. 1987 Nov;30(11):2105-9. doi: 10.1021/jm00394a029.
4
Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.顺式和反式-2-氨基-5-甲氧基-1-甲基四氢萘的拆分:中枢多巴胺受体激动剂和拮抗剂
J Med Chem. 1987 Apr;30(4):602-11. doi: 10.1021/jm00387a004.
5
8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.8-羟基-2-(烷基氨基)四氢萘及其相关化合物作为中枢5-羟色胺受体激动剂。
J Med Chem. 1984 Jan;27(1):45-51. doi: 10.1021/jm00367a009.
6
Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.8-羟基-2-(二正丙基氨基)四氢萘的C3-甲基化衍生物的中枢多巴胺能和5-羟色胺能效应
J Med Chem. 1988 Jun;31(6):1130-40. doi: 10.1021/jm00401a012.
7
Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.对自身受体具有优先作用的新型多巴胺受体激动剂和拮抗剂。
J Med Chem. 1985 Aug;28(8):1049-53. doi: 10.1021/jm00146a012.
8
C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors.7-羟基-2-(二正丙基氨基)四氢萘的C1和C3甲基取代衍生物:对中枢多巴胺受体的活性
J Med Chem. 1987 Oct;30(10):1827-37. doi: 10.1021/jm00393a025.
9
(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.(+)-AJ 76和(+)-UH 232:作为优先多巴胺自身受体拮抗剂的中枢兴奋剂。
Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):234-45. doi: 10.1007/BF00508777.
10
(+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.(+)-UH 232和(+)-UH 242:对自身受体具有优先作用的新型立体选择性多巴胺受体拮抗剂。
J Neural Transm. 1986;65(1):1-27. doi: 10.1007/BF01249608.

引用本文的文献

1
(+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.(+)-UH 232和(+)-UH 242:对自身受体具有优先作用的新型立体选择性多巴胺受体拮抗剂。
J Neural Transm. 1986;65(1):1-27. doi: 10.1007/BF01249608.